Search tips
Search criteria 


Logo of brjopthalBritish Journal of OphthalmologyVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
Br J Ophthalmol. 1990 June; 74(6): 353–357.
PMCID: PMC1042126

High-dose short-term chlorambucil for intractable sympathetic ophthalmia and Behçet's disease.


We treated five patients with intractable sympathetic ophthalmia and six patients with severe Behçet's disease by high-dose, short-term chlorambucil therapy. We used a total dose ranging from 306 mg to 4.2 g and a duration of therapy no longer than 36 weeks and in most cases less than 24 weeks. After termination of therapy all 11 patients had a sustained remission of their eye disease. Unless subretinal neovascularisation was present, all had a final visual acuity of 20/50 or better. Malignancy has not developed in any of our cases, with a follow-up ranging from 6 months to 12 years (mean, 4.5 years). Although 30- and 40-year follow-ups and larger numbers of patients may be necessary fully to realise the risks of chlorambucil, we believe that our high-dose, short-term regimen (Behçet's disease: average duration, 23 weeks; average total dose 2.2 g; sympathetic ophthalmia: average duration, 11 weeks; total average dose, 0.9 g) may be safer than previously reported chlorambucil regimens of one to two years or longer. In addition we fulfilled our aim of discontinuing all concomitant systemic corticosteroids within a relatively short time (usually six to eight weeks).

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1019K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Mamo JG, Azzam SA. Treatment of Behçet's disease with chlorambucil. Arch Ophthalmol. 1970 Oct;84(4):446–450. [PubMed]
  • Godfrey WA, Epstein WV, O'Connor GR, Kimura SJ, Hogan MJ, Nozik RA. The use of chlorambucil in intractable idiopathic uveitis. Am J Ophthalmol. 1974 Sep;78(3):415–428. [PubMed]
  • Elliott JH, Ballinger WH. Behçet's syndrome: treatment with chlorambucil. Trans Am Ophthalmol Soc. 1984;82:264–281. [PMC free article] [PubMed]
  • Mamo JG. Treatment of Behcet disease with chlorambucil. A follow-up report. Arch Ophthalmol. 1976 Apr;94(4):580–583. [PubMed]
  • Williams SA, Makker SP, Ingelfinger JR, Grupe WE. Long-term evaluation of chlorambucil plus prednisone in the idiopathic nephrotic syndrome of childhood. N Engl J Med. 1980 Apr 24;302(17):929–933. [PubMed]
  • Seidenfeld AM, Smythe HA, Ogryzlo MA, Urowitz MB, Dotten DA. Acute leukemia in rheumatoid arthritis treated with cytotoxic agents. J Rheumatol. 1976 Sep;3(3):295–304. [PubMed]
  • Berk PD, Goldberg JD, Silverstein MN, Weinfeld A, Donovan PB, Ellis JT, Landaw SA, Laszlo J, Najean Y, Pisciotta AV, et al. Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy. N Engl J Med. 1981 Feb 19;304(8):441–447. [PubMed]
  • Tabbara KF. Chlorambucil in Behçet's disease. A reappraisal. Ophthalmology. 1983 Aug;90(8):906–908. [PubMed]
  • Guesry P, Lenoir G, Broyer M. Gonadal effects of chlorambucil given to prepubertal and pubertal boys for nephrotic syndrome. J Pediatr. 1978 Feb;92(2):299–303. [PubMed]
  • Marak GE., Jr Recent advances in sympathetic ophthalmia. Surv Ophthalmol. 1979 Nov-Dec;24(3):141–156. [PubMed]
  • Snaith ML, Holt JM, Oliver DO, Dunnill MS, Halley W, Stephenson AC. Treatment of patients with systemic lupus erythematosus including nephritis with chlorambucil. Br Med J. 1973 Apr 28;2(5860):197–201. [PMC free article] [PubMed]
  • Patapanian H, Graham S, Sambrook PN, Browne CD, Champion GD, Cohen ML, Day RO. The oncogenicity of chlorambucil in rheumatoid arthritis. Br J Rheumatol. 1988 Feb;27(1):44–47. [PubMed]
  • Israel HL, Patchefsky AS, Saldana MJ. Wegener's granulomatosis, lymphomatoid granulomatosis, and benign lymphocytic angiitis and granulomatosis of lung. Recognition and treatment. Ann Intern Med. 1977 Dec;87(6):691–699. [PubMed]
  • Smulders FM, Oosterhuis JA. Treatment of Behcet's disease with chlorambucil. Ophthalmologica. 1975;171(4-5):347–352. [PubMed]
  • Abdalla MI, el-D Bahoat N. Long-lasting remission of Behcet's disease after chlorambucil therapy. Br J Ophthalmol. 1973 Sep;57(9):706–711. [PMC free article] [PubMed]
  • Kahn MF, Arlet J, Bloch-Michel H, Caroit M, Chaouat Y, Renier JC. Leucémies aiguës après traitement par agents cytotoxiques en rhumatologie. 19 observations chez 2006 patients. Nouv Presse Med. 1979 Apr 14;8(17):1393–1397. [PubMed]
  • Greene MH, Boice JD, Jr, Greer BE, Blessing JA, Dembo AJ. Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials. N Engl J Med. 1982 Dec 2;307(23):1416–1421. [PubMed]
  • Tchernia G, Mielot F, Subtil E, Parmentier C. Acute myeloblastic leukemia after immunodepressive therapy for primary nonmalignant disease. Nouv Rev Fr Hematol Blood Cells. 1976;17(1-2):67–80. [PubMed]
  • Tulliez M, Ricard MF, Jan F, Sultan C. Preleukaemic abnormal myelopoiesis induced by chlorambucil: a case study. Scand J Haematol. 1974;13(3):179–183. [PubMed]
  • Westberg NG, Swolin B. Acute myeloid leukemia appearing in two patients after prolonged continuous chlorambucil treatment for Wegener's granulomatosis. Acta Med Scand. 1976;199(5):373–377. [PubMed]
  • Lebranchu Y, Drucker J, Nivet H, Rolland JC, Grenier B, Lejars O, Lamagnere JP, Buriot D. Acute monoblastic leukaemia in child receiving chlorambucil for juvenile rheumatoid arthritis. Lancet. 1980 Mar 22;1(8169):649–649. [PubMed]
  • Lenoir G, Guesry P, Kleinknecht C, Gagnadoux MF, Broyer M. Complications extragonadiques du chlorambucil chez l'enfant (a propos de 300 observations de néphropathies glomérulaires traitées. Arch Fr Pediatr. 1977 Oct;34(8):798–807. [PubMed]
  • Zittoun R, Debré P, Gardais J, Thuau FP, Renier JC, Simon F. Lymphosarcome du grêle après traitement d'une polyarthrite rhumatoïde par le chlorambucil. Nouv Presse Med. 1972 Oct 21;1(37):2477–2479. [PubMed]
  • Deshayes P, Rénier JC, Bregeon C, Houdent G. Incidents et accidents des thérapeutiques a visée immunodépressive dans la polyarthrite rhumatoïde. Rev Rhum Mal Osteoartic. 1971 Dec;38(12):797–806. [PubMed]
  • Callis L, Nieto J, Vila A, Rende J. Chlorambucil treatment in minimal lesion nephrotic syndrome: a reappraisal of its gonadal toxicity. J Pediatr. 1980 Oct;97(4):653–656. [PubMed]
  • Richter P, Calamera JC, Morgenfeld MC, Kierszenbaum AL, Lavieri JC, Mancini RE. Effect of chlorambucil on spermatogenesis in the human with malignant lymphoma. Cancer. 1970 May;25(5):1026–1030. [PubMed]
  • Miller DG. Alkylating agents and human spermatogenesis. JAMA. 1971 Sep 20;217(12):1662–1665. [PubMed]
  • Cheviakoff S, Calamera JC, Morgenfeld M, Mancini RE. Recovery of spermatogenesis in patients with lymphoma after treatment with chlorambucil. J Reprod Fertil. 1973 Apr;33(1):155–157. [PubMed]
  • Scammell GE, White N, Stedronska J, Hendry WF, Edmonds DK, Jeffcoate SL. Cryopreservation of semen in men with testicular tumour or Hodgkin's disease: results of artificial insemination of their partners. Lancet. 1985 Jul 6;2(8445):31–32. [PubMed]
  • Guesry P, Lenoir G, Broyer M. Action à long terme des immunosuppresseurs sur la fonction de reproduction. Arch Fr Pediatr. 1977 Oct;34(8):792–798. [PubMed]
  • Sobrinho LG, Levine RA, DeConti RC. Amenorrhea in patients with Hodgkin's disease treated with antineoplastic agents. Am J Obstet Gynecol. 1971 Jan 1;109(1):135–139. [PubMed]
  • Morgenfeld MC, Goldberg V, Parisier H, Bugnard SC, Bur GE. Ovarian lesions due to cytostatic agents during the treatment of Hodgkin's disease. Surg Gynecol Obstet. 1972 May;134(5):826–828. [PubMed]
  • Steege JF, Caldwell DS. Renal agenesis after first trimester exposure to chlorambucil. South Med J. 1980 Oct;73(10):1414–1415. [PubMed]
  • Gaminara EJ, Pearson TC. Chlorambucil-induced myelofibrosis. Clin Lab Haematol. 1984;6(3):293–297. [PubMed]
  • Rudd P, Fries JF, Epstein WV. Irreversible bone marrow failure with chlorambucil. J Rheumatol. 1975 Dec;2(4):421–429. [PubMed]
  • Peterman A, Braunstein B. Cutaneous reaction to chlorambucil therapy. Arch Dermatol. 1986 Dec;122(12):1358–1360. [PubMed]
  • Carr ME., Jr Chlorambucil induced pulmonary fibrosis: report of a case and review. Va Med. 1986 Nov;113(11):677–680. [PubMed]
  • Fauci AS, Katz P, Haynes BF, Wolff SM. Cyclophosphamide therapy of severe systemic necrotizing vasculitis. N Engl J Med. 1979 Aug 2;301(5):235–238. [PubMed]
  • Palmer RG, Dore CJ, Denman AM. Cyclophosphamide induces more chromosome damage than chlorambucil in patients with connective tissue diseases. Q J Med. 1986 Apr;59(228):395–400. [PubMed]
  • Chabner BA, Myers CE, Coleman CN, Johns DG. The clinical pharmacology of antineoplastic agents (second of two parts). N Engl J Med. 1975 May 29;292(22):1159–1168. [PubMed]
  • Wall RL, Clausen KP. Carcinoma of the urinary bladder in patients receiving cyclophosphamide. N Engl J Med. 1975 Aug 7;293(6):271–273. [PubMed]
  • Pedersen-Bjergaard J, Ersbøll J, Hansen VL, Sørensen BL, Christoffersen K, Hou-Jensen K, Nissen NI, Knudsen JB, Hansen MM. Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma. N Engl J Med. 1988 Apr 21;318(16):1028–1032. [PubMed]
  • Graham EM, Sanders MD, James DG, Hamblin A, Kasp Grochowska E, Dumonde D. Cyclosporin A in the treatment of posterior uveitis. Trans Ophthalmol Soc U K. 1985;104(Pt 2):146–151. [PubMed]
  • Nussenblatt RB, Palestine AG, Rook AH, Scher I, Wacker WB, Gery I. Treatment of intraocular inflammatory disease with cyclosporin A. Lancet. 1983 Jul 30;2(8344):235–238. [PubMed]
  • Nussenblatt RB, Palestine AG, Chan CC, Mochizuki M, Yancey K. Effectiveness of cyclosporin therapy for Behçet's disease. Arthritis Rheum. 1985 Jun;28(6):671–679. [PubMed]
  • Palestine AG, Austin HA, 3rd, Balow JE, Antonovych TT, Sabnis SG, Preuss HG, Nussenblatt RB. Renal histopathologic alterations in patients treated with cyclosporine for uveitis. N Engl J Med. 1986 May 15;314(20):1293–1298. [PubMed]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group